Operating Lease, Right-of-Use Asset of Apyx Medical Corp from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Apyx Medical Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Apyx Medical Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,342,000, a 9.9% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Apyx Medical Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,342,000 -$478,000 -9.9% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $4,464,000 -$471,000 -9.5% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $4,584,000 -$465,000 -9.2% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,703,000 -$459,000 -8.9% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $4,820,000 -$454,000 -8.6% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $4,935,000 -$486,000 -9% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $5,049,000 +$4,403,000 +682% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $5,162,000 +$4,452,000 +627% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $5,274,000 +$4,500,000 +581% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $5,421,000 +$4,762,000 +723% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $646,000 +$556,000 +618% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $710,000 +$589,000 +487% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $774,000 +$622,000 +409% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $659,000 +$477,000 +262% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $90,000 -$122,000 -58% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $121,000 -$116,000 -49% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $152,000 -$114,000 -43% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $182,000 -$113,000 -38% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $212,000 -$110,000 -34% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 $237,000 -$113,000 -32% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $266,000 -$102,000 -28% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $295,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $322,000 +$144,000 +81% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $350,000 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $368,000 30 Sep 2019 10-Q 15 Nov 2019 2019 Q3
Q1 2019 $178,000 31 Mar 2019 10-K 31 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.